Although AIM2 was thought to be a tumor suppressor, overexpression of AIM2 and IFI16 synergistically promotes OSCC cell growth and prevents apoptosis via activating NF-κB pathway, which suggests the oncogenic potential of AIM2 and IFI16 in OSCC (65). The gene discussed is AIM2; the disease is neoplasm.